Grünenthal USA Inc.
Partner in Pain Management
Grünenthal USA is a subsidiary of Grünenthal GmbH, an independent, family-owned pharmaceutical company specializing in pain management.
Grünenthal USA partners with other leading pharmaceutical companies to deliver innovative products to patients living with pain.
Grünenthal USA, Inc.
360 Mount Kemble Avenue
Morristown, NJ 07960
New Chief Executive Officer Grünenthal Group
Gabriel Baertschi follows Eric-Paul Pâques as CEO as of
The Grünenthal Group announces that Gabriel Baertschi has taken office as new CEO of the Grünenthal Group, The company’s Supervisory Board had named Gabriel Baertschi to become Grünenthal’s new Chief Executive Officer in June 2016. Gabriel Baertschi is joining Grünenthal from AstraZeneca, a global, science-led biopharmaceutical business where in his last appointment he served as country president for Japan.
Gabriel Baertschi has more than 20 years of international experience in the pharmaceutical industry, and succeeds Prof. Dr. Eric-Paul Pâques who retires at the end of 2016 after 23 years at Grünenthal.